Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Dubin-Johnson syndrome is a rare, benign, inherited disorder characterized by chronic or intermittent mild jaundice caused by the liver's inability to properly secrete conjugated bilirubin into the bile. Because it is a harmless condition that does not cause liver damage or affect life expectancy, most individuals with Dubin-Johnson syndrome require no medical treatment. What is Dubin-Johnson syndrome and how does it affect the body? Dubin-Johnson syndrome is a chronic metabolic condition that primarily affects the liver.
TL;DR: Dubin-Johnson syndrome is a rare, benign, inherited disorder characterized by chronic or intermittent mild jaundice caused by the liver's inability to properly secrete conjugated bilirubin into the bile. Because it is a harmless condition that does not cause liver damage or affect life expectancy, most individuals with Dubin-Johnson syndrome require no medical treatment.
Dubin-Johnson syndrome is a chronic metabolic condition that primarily affects the liver. In a healthy liver, bilirubin—a yellow pigment produced by the breakdown of red blood cells—is processed and moved into the bile for excretion. In individuals with Dubin-Johnson syndrome, the protein responsible for transporting this bilirubin out of the liver cells and into the bile ducts is defective. As a result, conjugated bilirubin accumulates in the liver cells and leaks back into the bloodstream, leading to mild jaundice (yellowing of the skin and whites of the eyes). A hallmark feature of Dubin-Johnson syndrome is the presence of a dark, melanin-like pigment in the liver cells, which turns the liver a characteristic black or dark brown color, though this does not impair liver function.
Yes, Dubin-Johnson syndrome is a genetic disorder inherited in an autosomal recessive pattern. This means an individual must inherit two copies of the mutated gene—one from each parent—to manifest the condition. The underlying cause is a mutation in the ABCC2 gene, which provides instructions for making the MRP2 protein (multidrug resistance-associated protein 2). When this protein is absent or non-functional, the liver cannot effectively clear bilirubin.
Dubin-Johnson syndrome is considered very rare in the general population, though it is notably more frequent in certain populations, particularly among Iranian Jews, where the carrier frequency is estimated to be as high as 1 in 1,300. The condition typically presents during adolescence or early adulthood, although it can be diagnosed at any age. It affects males and females equally, and because the condition is benign, many people remain undiagnosed until they undergo routine blood work that reveals elevated bilirubin levels.
It is common to confuse Dubin-Johnson syndrome with other hereditary hyperbilirubinemias. Key clinical differences include:
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician regarding any medical condition.